This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/Gabapentin: Difference between revisions
Jump to navigation
Jump to search
>Reddit-Drug-Advice The previous dosage ranges for gabapentin were extremely low compared to common use reported on Erowid and other forums, especially compared to the suggested ranges for pregabalin considering the medical equivalency evidence suggesting a 5:1 conversion ratio gaba:pregab (https://ahpnetwork.com/wp-content/uploads/2018/05/Admelog-May-2018.pdf , https://pubmed.ncbi.nlm.nih.gov/21692969/). Based on my experience and research I consider these new dose ranges much more realistic. |
>Reddit-Drug-Advice "Peak plasma concentrations were similar across the entire age group and occurred 2 to 3 hours postdose" - https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020235s064_020882s047_021129s046lbl.pdf , https://sci-hubtw.hkvisa.net/10.1016/s0920-1211(98)00020-5 |
||
| Line 62: | Line 62: | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
|OralROA_Duration=[[Oral min total time:: | |OralROA_Duration=[[Oral min total time::6]] - [[Oral max total time::10]] [[Oral total time units::hours]] | ||
|OralROA_Onset=[[Oral min onset time::30]] - [[Oral max onset time:: | |OralROA_Onset=[[Oral min onset time::30]] - [[Oral max onset time::120]] [[Oral onset time units::minutes]] | ||
|OralROA_Peak= | |OralROA_Peak=[[Oral min peak time::120]] - [[Oral max peak time::180]] [[Oral onset time units::minutes]] | ||
|OralROA_Offset= | |OralROA_Offset= | ||
|OralROA_Aftereffects= | |OralROA_Aftereffects= | ||
}} | }} | ||
Revision as of 20:35, 28 October 2021
| SubstanceBox/Gabapentin | |||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |
|||||||||||||||||||||||||||||
| Chemical Nomenclature | |||||||||||||||||||||||||||||
| Common names | Gabapentin, Neurontin, Gabarone, Gralise | ||||||||||||||||||||||||||||
| Substitutive name | Gabapentin | ||||||||||||||||||||||||||||
| Systematic name | 1-(Aminomethyl)cyclohexaneacetic acid | ||||||||||||||||||||||||||||
| Class Membership | |||||||||||||||||||||||||||||
| Psychoactive class | Depressant | ||||||||||||||||||||||||||||
| Chemical class | Gabapentinoid | ||||||||||||||||||||||||||||
| Routes of Administration | |||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||
- ↑ "Gabapentin dosing, indications, interactions, adverse effects, and more". | http://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011#showall